2-Aminoadipic acid is a biomarker for diabetes risk

Journal of Clinical Investigation

Volumn 123, Issue 10, 2013, Pages 4309-4317

  Wang, Thomas J ^a,b,c   Ngo, Debby ^a,d   Psychogios, Nikolaos ^a   Dejam, Andre ^a   Larson, Martin G ^b,e   Vasan, Ramachandran S ^b,f   Ghorbani, Anahita ^a,b   O'Sullivan, John ^a   Cheng, Susan ^b,d   Rhee, Eugene P ^a,g   Sinha, Sumita ^a   McCabe, Elizabeth ^b   Fox, Caroline S ^b,h,i   O'Donnell, Christopher J ^a,b,i   Ho, Jennifer E ^b,f   Florez, Jose C ^a,g   Magnusson, Martin ^j,k   Pierce, Kerry A ^g   Souza, Amanda L ^g   Yu, Yi ^l   Carter, Christian ^l   Light, Peter E ^l   Melander, Olle ^j,k   Clish, Clary B ^g   Gerszten, Robert E ^a,g   more..

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e Broad Institute of MIT and Harvard ^*  (United States)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^j LUND UNIVERSITY HOSPITAL   (Sweden)

^k LUND UNIVERSITY   (Sweden)

^l UNIVERSITY OF ALBERTA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOADIPIC ACID; AROMATIC AMINO ACID; BRANCHED CHAIN AMINO ACID; INSULIN; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

ADULT; AMINO ACID BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; EXPERIMENTAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; INSULIN RELEASE; LIPID DIET; MAJOR CLINICAL STUDY; MALE; METABOLOMICS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RISK ASSESSMENT; AGED; ANIMAL; ANTIBODY SPECIFICITY; BLOOD; C57BL MOUSE; CELL LINE; DIABETES MELLITUS, TYPE 2; HOMEOSTASIS; METABOLISM; METABOLOME; MIDDLE AGED; REPRODUCIBILITY; RISK; SECRETION (PROCESS); TISSUE CULTURE TECHNIQUE;

2-AMINOADIPIC ACID; AGED; ANIMALS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CELL LINE; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; FEMALE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MALE; METABOLOME; MICE; MICE, INBRED C57BL; MIDDLE AGED; ORGAN SPECIFICITY; REPRODUCIBILITY OF RESULTS; RISK; TISSUE CULTURE TECHNIQUES;

EID: 84885031125     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI64801     Document Type: Article

References (28)

1. Pan XR, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537-544.
2. Tuomilehto J, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343-1350.
3. Knowler WC, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
4. Gerstein HC, et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet. 2006;368(9541):1096-1105.
5. Gieger C, et al. Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet. 2008;4(11):e1000282.
6. Suhre K, et al. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS One. 2010;5(11):e13953.
7. Suhre K, et al. Human metabolic individuality in biomedical and pharmaceutical research. Nature. 2011;477(7362):54-60.
8. Wang TJ, et al. Metabolite profiles and the risk of developing diabetes. Nat Med. 2011;17(4):448-453.
9. Rhee EP, et al. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest. 2011;121(4):1402-1411.
10. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol. 1992;135(10):1114-1126.
11. Pencina MJ, D'Agostino RB, D'Agostino RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157-172.
12. Requena JR, Chao CC, Levine RL, Stadtman ER. Glutamic and aminoadipic semialdehydes are the main carbonyl products of metal-catalyzed oxidation of proteins. Proc Natl Acad Sci U S A. 2001;98(1):69-74.
13. Fan X, et al. Mechanism of lysine oxidation in human lens crystallins during aging and in diabetes. J Biol Chem. 2009;284(50):34618-34627.
14. Sell DR, Strauch CM, Shen W, Monnier VM. 2-aminoadipic acid is a marker of protein carbonyl oxidation in the aging human skin: effects of diabetes, renal failure and sepsis. Biochem J. 2007;404(2):269-277.
15. Tsutsui H, et al. Practical analytical approach for the identification of biomarker candidates in prediabetic state based upon metabonomic study by ultraperformance liquid chromatography coupled to electrospray ionization time-of-flight mass spectrometry. J Proteome Res. 2010;9(8):3912-3922.
16. Wijekoon EP, Skinner C, Brosnan ME, Brosnan JT. Amino acid metabolism in the Zucker diabetic fatty rat: effects of insulin resistance and of type 2 diabetes. Can J Physiol Pharmacol. 2004;82(7):506-514.
17. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest. 1999;104(6):787-794.
18. Felig P, Marliss E, Cahill GF. Plasma amino acid levels and insulin secretion in obesity. N Engl J Med. 1969;281(15):811-816.
19. Wahren J, Felig P, Cerasi E, Luft R. Splanchnic and peripheral glucose and amino acid metabolism in diabetes mellitus. J Clin Invest. 1972;51(7):1870-1878.
20. Wahren J, Felig P, Hagenfeldt L. Effect of protein ingestion on splanchnic and leg metabolism in normal man and in patients with diabetes mellitus. J Clin Invest. 1976;57(4):987-999.
21. Liu Z, Jeppesen PB, Gregersen S, Chen X, Hermansen K. Dose- and glucose-dependent effects of amino acids on insulin secretion from isolated mouse islets and clonal INS-1E β-cells. Rev Diabet Stud. 2008;5(4):232-244.
22. Um SH, D'Alessio D, Thomas G. Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab. 2006;3(6):393-402.
23. Newgard CB, et al. A branched-chain amino acidrelated metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009;9(4):311-326.
24. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol. 1979;110(3):281-290.
25. Persson M, Hedblad B, Nelson JJ, Berglund G. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects. Arterioscler Thromb Vasc Biol. 2007;27(6):1411-1416.
26. Roberts LD, Souza AL, Gerszten RE, Clish CB. Targeted metabolomics. Curr Protoc Mol Biol. 2012; Chapter 30:Unit 30. 2. 1-30. 2. 24.
27. Hamming KS, et al. Inhibition of beta-cell sodiumcalcium exchange enhances glucose-dependent elevations in cytoplasmic calcium and insulin secretion. Diabetes. 2010;59(7):1686-1693.
28. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulinresistance and beta cellfunctionfromfasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419.